Yahoo Finance report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
Why APT Stock surged +2.22% Today — RQD Quant Desk Flash
Alpha Pro Tech Ltd. (APT) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Alpha Pro Tech Ltd. (NYSE: APT) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $5.52 (+2.22% 1D, market cap $55.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, APT ranks #160 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does APT compare to COCH and MYO in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), APT carries a Roarable C- (61/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, COCH (Envoy Medical Inc. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $51.3M) and MYO (Myomo Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $49.1M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for APT?
▼
Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 5.59 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9
FRED Regime × Technicals: 37% of 52W Range • RSI-14 at 46.9 (NEUTRAL RANGE)
Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)
⚔️ Adversarial Opposing Case: Why the APT Bull Thesis Could Fail
Even with a 61/100 (C-) score, APT faces multiple-compression risk if 16.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 35.6% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($5.40) or 200D SMA ($5.20) invalidates the momentum regime and cuts Target Base ($5.59) toward Bear Floor ($4.36).
Why APT Stock surged +2.22% Today — RQD Quant Desk Flash
Alpha Pro Tech Ltd. (APT) surged +2.22% to $5.52, trading at 37% of its 52-week range ($4.34 – $7.5). Solid 38% profit margin (7% return on capital), mixed timing at 16x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 37% of its 52-week range ($4.34 – $7.5) with RSI-14 at 46.9 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.7% around $5.52 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 38.1% gross margin and $1.7M annual free cash flow.
Investing.com Nigeria report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
First Quarter Net Sales Increased by 5.5% to $14.6 Million, Compared to $13.8 Million for the First Quarter of 2025 Net sales for the first quarter of 2026 were $14.6 million, up 5.5% compared to $13.8 million for the fi
Aptos has taken its optional privacy feature live, allowing users to encrypt APT balances and transfer amounts while keeping wallet addresses visible.
No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.
Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior Year Period Net sales
Bitcoin’s move back above $78,000 is starting to pull more risk appetite with it, and meme-linked tokens are ...
Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024 Net sales for the year ended December 31, 2025, were $59.1 million, up 2.3% compared to $57.8 million for the
Scheduled RQD Strong Buys & Whale Accumulation Briefing (APT Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
APT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on APT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for APT. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (APT)
1. Head-to-Head Health Care Peer Comparison (APT vs. COCH, MYO, NTRB, CNXU)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Alpha Pro Tech Ltd. (APT) ranks #160 by composite RQD confidence (61/100, grade C-) and #728 by equity capitalization ($55.1M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| APT
ACTIVE
Alpha Pro Tech Ltd. | C- | 61/100 | 16.2x | 38.1% | 6.7% | +2.22% | $55.1M | Benchmark Subject |
| COCH Envoy Medical Inc. (Class A) | D- | 36/100 | — | -30.0% | -35.0% | +0.30% | $51.3M | /coch-vs-apt → |
| MYO Myomo Inc. | E | 31/100 | — | 65.7% | -35.0% | -3.23% | $49.1M | /myo-vs-apt → |
| NTRB Nutriband Inc. | D- | 37/100 | — | 27.8% | -35.0% | +1.75% | $76.6M | /ntrb-vs-apt → |
| CNXU Conexeu Sciences Inc. | D- | 43/100 | — | — | — | -5.51% | $77.0M | /cnxu-vs-apt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884269In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported GAAP revenue of $59.1M (+2.3% vs. FY2024 revenue of $57.8M , and +411.2% cumulative change since FY2023) , GAAP net income of $3.5M, operating cash flow of $2.4M, and free cash flow of $1.7M (-8.5% YoY). On the balance sheet, APT closed FY2025 with $74.1M in total assets against $0 in total debt (Altman Z-Score: 5.59, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $59.1M | $3.5M | $2.4M | $1.7M | $74.1M | — |
| FY2024 (FY) | 2024-12-31 | $57.8M | $3.9M | $5.7M | $1.9M | $73.7M | — |
| FY2023 (FY) | 2023-12-31 | $11.6M | $4.2M | $8.5M | $8.5M | — | — |
3. APT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Alpha Pro Tech Ltd. (NYSE: APT) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $5.52 (+2.22% 1D, market cap $55.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, APT ranks #160 in composite RQD confidence.
How does APT compare to COCH and MYO in the Health Care sector?
Within the Health Care sector (Industrial Specialties), APT carries a Roarable C- (61/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, COCH (Envoy Medical Inc. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $51.3M) and MYO (Myomo Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $49.1M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for APT?
Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is APT trading relative to its 50-day, 200-day, and 52-week technical levels?
APT last traded at $5.52 (+2.22% on volume of 61,107 shares), positioning the stock +2.22% above its 50-day simple moving average ($5.40) and +6.15% above its 200-day simple moving average ($5.20). Across its 52-week range of $4.34 to $7.50, APT sits at the 37.3% percentile with a 14-day RSI of 46.9 (NEUTRAL RANGE) and an implied next-earnings move of ±7.7% ($5.09 to $5.95).
APT — Alpha Pro Tech Ltd.: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Alpha Pro Tech Ltd. (APT) earns a live Roarable RQD composite score of 61/100, corresponding to a C- letter grade (Roarable Hold) at a spot price of $5.52 (+2.22% 1D, market capitalization $55.1M).
- Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of 6.7%, gross margin of 38.1%, operating margin of 6.5%, and free cash flow yield of 3.06%.
- Whale 13F & Options Flow (8/20) + Insider Conviction (16/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (13/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of 5.59, Piotroski F-Score of 5/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Alpha Pro Tech Ltd. (APT) is a NYSE-listed issuer classified in the Health Care sector and the Industrial Specialties industry,. Per the market data, gross margin is 38.1%.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported $59.1M in annual revenue (up from $57.8M in FY2024, +2.3% YoY) and $3.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($11.6M revenue, $4.2M net income) through FY2025, APT scaled operating cash flow to $2.4M and free cash flow to $1.7M, backed by $74.1M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (C- • RQD 61/100): Clean SEC annual filing review with no major hidden accounting time-bombs. Free cash flow yield of 3.06% and institutional whale pillar of 8/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 8/20, sustained execution supports upside toward the upper end of the $4.34 – $7.50 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 16.2x trailing P/E and 9.0x EV/EBITDA against 6.5% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream suppliers, downstream customers, and sector correlations are — A prospective investor should monitor whether future filings identify key input suppliers or concentrated customers, since no second-order exposures can be mapped from the current data.
- Key Question #1: Can APT sustain or expand its 6.5% operating margin and 6.7% ROIC against Industrial Specialties peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $59.1M and free cash flow of $1.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is APT's 15.1x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
APT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Alpha Pro Tech Ltd. (APT) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
Investing.com Nigeria report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Alpha Pro Tech Ltd. (APT) market action, institutional positioning, and fundamental catalysts.
First Quarter Net Sales Increased by 5.5% to $14.6 Million, Compared to $13.8 Million for the First Quarter of 2025 Net sales for the first quarter of 2026 were $14.6 million, up 5.5% compared to $13.8 million for the fi
Aptos has taken its optional privacy feature live, allowing users to encrypt APT balances and transfer amounts while keeping wallet addresses visible.
No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.
Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior Year Period Net sales
APT Bull vs. Bear Conversation Board — What's Your Call at $5.52?
A 16 forensic-balance-sheet pillar score, Altman Z of 5.59, and Debt/Equity of 0.5 point to a financially resilient balance sheet at a
Here is why I am bullish on APT here at $5.40: A 16 forensic-balance-sheet pillar score, Altman Z of 5.59, and Debt/Equity of 0.5 point to a financially resilient balance sheet at a P/E of 16.2.. Compare APT's 6.5% operating margin and 6.7% ROIC against the rest of Industrial Specialties. As long as cash conversion holds up, dips toward $5.13 are getting bought.
@MeanReversion_88 Shorting a 8/20 institutional whale-flow stock at $5.40 is dangerous when funds are rotating into Health Care.
A 9 of 20 whale 13F flow score and ROIC of 6.7% indicate weak institutional conviction and modest returns on capital.
I respect the product at Alpha Pro Tech Ltd., but the stock at $5.40 is a different story. A 9 of 20 whale 13F flow score and ROIC of 6.7% indicate weak institutional conviction and modest returns on capital.. FCF yield is 3.06% and RQD sits at 61/100 (C-) — why pay up here when you can wait for next quarter's numbers?